Table 2.
The final diagnosis of pancreatic lesions-entire cohort (general model and PSM model)2
| General model | PSM model | |||
|---|---|---|---|---|
| EUS-guided biopsy (n = 444) | US-guided biopsy (n = 2139) | EUS-guided biopsy (n = 402) | US-guided biopsy (n = 402) | |
| Biopsy pathology | ||||
| PDAC | 324 | 1826 | 289 | 328 |
| PNET | 12 | 59 | 11 | 15 |
| SPTP | 7 | 4 | 7 | 1 |
| Inflammation | 21 | 87 | 20 | 15 |
| Other malignancies | 9 | 69 | 8 | 8 |
| Benign tumors | 0 | 12 | 0 | 0 |
| Undefined results | 71 | 82 | 67 | 35 |
| Final diagnosis | ||||
| PDAC | 349 | 1898 | 312 | 363 |
| PNET | 15 | 65 | 14 | 15 |
| SPTP | 7 | 4 | 7 | 1 |
| Inflammation | 43 | 87 | 42 | 13 |
| Other malignancies | 12 | 69 | 11 | 8 |
| Benign tumors | 13 | 16 | 11 | 2 |
| Undefined results | 5 | 0 | 5 | 0 |
2.
EUS: endoscopic ultrasound, US: ultrasound, PSM: propensity score matching, PDAC: pancreatic ductal adenocarcinoma, PNET: pancreatic neuroendocrine tumor, SPTP: solid pseudopapillary tumor of the pancreas.